ArticleCancer medicine2023

Compliance to genomic test recommendations to guide adjuvant chemotherapy decision-making in the case of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, in real-life settings.

D Hequet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.